Business Wars Daily cover image

Male Birth Control Startup Gets $7 Million

Business Wars Daily

00:00

Adam: A Non-Hormonal Reversible Birth Control for Men

David Brown: For decades, the dominant narrative around birth control has been that it's for women. He says a Virginia-based pharma company is turning their focus to birth control for men and those who've been assigned male at birth. Contraline just wrapped up a $7 million funding round with its new non-hormonal reversible birth control product called Adam. The gel immediately blocks the flow of sperm, but over time it disintegrates, which makes it temporary.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app